These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Not reported 2005-000346-36 A Phase III, Multi-centre, Randomised, Parallel Group Study of Safety and Efficacy of LB03002, a New Sustained Release Formulation of Human Recombinant Growth Hormone as Compared to Standard Daily The... 2010-06-07 due-trials
Listed as ongoing, but also has a completion date 2005-000384-26 A phase III, double-blind, randomized, placebo-controlled, parallel-group, multicenter study to assess efficacy and safety of LB03002 administered weekly in adults with growth hormone deficiency. 2008-03-04 bad-data
Listed as ongoing, but also has a completion date 2006-002278-24 A phase III, open-label, uncontrolled, multicentre, rollover study to assess safety and efficacy of LB03002 administered weekly in adults with growth hormone deficiency. 2008-09-05 bad-data